SiO2 Material Science

Activities: Drug Delivery Pharmaceutical

Trending Articles

  1. Autolus Therapeutics' CAR-T therapy, Aucatzyl, bags FDA approval for ALL Aucatzyl (obecabtagene autoleucel) is the first CAR-T therapy to receive FDA approval with no risk evaluation mitigation strategy requirement
  2. LEWA optimises Bachem's oligonucleotide production through inline dilution system This system allows for a flow rate of 2,500 L per hour, while also enabling flexible buffer production with varying flow rates
  3. AstraZeneca and Amgen's Tezspire meets primary endpoints in Phase III trial The Phase III WAYPOINT trial demonstrated Tezspire's ability to reduce nasal polyps and congestion compared to placebo when administered subcutaneously
  4. Romaco showcases its solid dosage processing portfolio at CPHI & PMEC India The company will display its portfolio suitable for the granulation, tableting, and coating of pharmaceutical solids
  5. Evotec strikes up a deal with Monacum Partners to sell its Halle API manufacturing facility The CDMO faction of Evotec will now function as DAPIN GmbH, which will continue to specialise in end-to-end chemical API development and manufacturing

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Manufacturing

Glass or polymer? swissfillon and SiO2 collaborate to deliver the best of both worlds in high quality filling

Fill and finish CDMO swissfillon and material science company SiO2 gave a joint presentation at MC Live to explain how their partnership is helping to develop innovative technology for complex drug products. Dr Kevin Robinson spoke to Carole Delauney, swissfillon’s Business Development Director, and Holger Krenz, SiO2’s Vice President, Applications Development Europe, to discuss the challenges of next-generation drug delivery and how such close collaborations can achieve better solutions
Drug Delivery

R+D Custom Automation makes deal with SiO2 on coronavirus vials

The agreement accelerates the production of SiO2's patented plastic vials for storing novel coronavirus vaccines and therapeutics
Subscribe now